Glycogenin 1 Antikörper (GYG1) (Cy5)

Details for Product anti-GYG1 Antibody No. ABIN1704673
Antigen
  • GSD15
  • GYG
  • Gyg
  • gyg
  • fc13d04
  • fi23f07
  • gyg1
  • wu:fc13d04
  • wu:fi23f07
  • zgc:55385
  • zgc:85619
  • glycogenin-1
  • MGC79098
  • GYG1
  • glycogenin 1
  • glycogenin 1a
  • glycogenin 1 S homeolog
  • GYG1
  • Gyg1
  • gyg1
  • gyg1a
  • gyg1.S
Reaktivität
Human, Maus, Ratte (Rattus)
59
43
39
1
1
1
1
1
Wirt
Kaninchen
47
12
Klonalität
Polyklonal
Konjugat
Dieser Glycogenin 1 Antikörper ist konjugiert mit Cy5
2
2
2
2
2
2
2
2
2
2
2
2
2
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
36
25
14
12
5
1
Optionen
Immunogen KLH conjugated synthetic peptide derived from human Glycogenin 1
Isotyp IgG
Reinigung Purified by Protein A.
Plasmids, Primers & others Plasmide, Primers & weitere Glycogenin 1 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung Glycogenin 1 (GYG1 Antibody Abstract)
Hintergrund

Glycogen synthesis is initiated by the autoglucosylation of Glycogenin-1. Specifically, Glycogenin-1 glucosylates itself to begin the synthesis of glycogen in mammalian skeletal muscle. It acts as the primer to which further glucose monomers may be added. All of the Glycogenin-1 Molecules contain at least one glucosyl residue before autoglucosylation begins. The first step of the glycogen synthesis occurs when a glucose molecule from UDP-glucose binds to the hydroxyl group of Tyr 194 on the Glycogenin-1 Molecule. Using its glucosyltransferase activity, Glycogenin-1 adds more glucoses, each one coming from UDP-glucose. The glycosylation process reaches a plateau when five new glucose residues have been added, at which point glycogen synthase (GS) takes over and further elongates the chain. Glycogenin-1 remains covalently attached to the reducing end of the glycogen molecule.

Synonyms: Glycogenin, Glycogenin-1, Glycogenin1, GLYG_HUMAN, GN-1, GN1, GYG 1, GYG, GYG1.

Pathways Cellular Glucan Metabolic Process
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?